Is It Obesity or Lipedema? UA Researcher Receives Grant To Study Genetic Risk Factors: Yann Klimentidis, PhD, a genetic epidemiologist at the University of Arizona Mel and Enid Zuckerman College of Public Health, has received funding to study the genetic risk factors for developing lipedema, a painful and body disfiguring condition affecting an estimated 11 percent of U.S. adult women.Continue reading→

From his roots as a fair-haired Minnesota farm boy to climbing the ladder of success in big pharma, to blazing a translational academic research path into life-saving therapies, Charles Arntzen has led one extraordinary life in science.   

Continue reading→

The ‘topping-off’ ceremony for the new $165 million University of Arizona Health Sciences Innovation Building signals the advancement of team-based health professions education in the United States. Continue reading→

Project aims to develop a prognostic test to improve prediction of ALS disease progression Continue reading→

More than one-third of study participants in Phase 2 Study were Cord Blood Registry® (CBR®) clients.Continue reading→

Preoperative Planning Tool Has the Potential for Changing the Management of Cerebral Aneurysm TreatmentContinue reading→

A special BIO 2018 discount for Affiliate Biotech AssociationsContinue reading→

Roche (SIX: RO, ROG; OTCQX:RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved the VENTANA ALK (D5F3) CDx Assay¹ for use on the VENTANA BenchMark ULTRA automated slide stainer. The assay is a companion diagnostic to aid in the identification of ALK-positive lung cancer patients who are eligible for treatment with Pfizer’s FDA-approved therapy XALKORI^®(crizotinib).² Continue reading→

EpiFinder offers a proven tool that empowers people to take ownership of their health, connect with their doctor, advance epilepsy and neurology research and is telling their story on KickStarter.Continue reading→